145 related articles for article (PubMed ID: 2209683)
1. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.
Hasbold J; Klaus GG
Eur J Immunol; 1990 Aug; 20(8):1685-90. PubMed ID: 2209683
[TBL] [Abstract][Full Text] [Related]
2. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells.
Pennell CA; Scott DW
Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148
[TBL] [Abstract][Full Text] [Related]
5. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
Baluyut AR; Subbarao B
J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
[TBL] [Abstract][Full Text] [Related]
6. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent.
Warner GL; Ludlow JW; Nelson DA; Gaur A; Scott DW
Cell Growth Differ; 1992 Mar; 3(3):175-81. PubMed ID: 1633108
[TBL] [Abstract][Full Text] [Related]
7. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL.
Yi AK; Hornbeck P; Lafrenz DE; Krieg AM
J Immunol; 1996 Dec; 157(11):4918-25. PubMed ID: 8943396
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
Santos-Argumedo L; Gordon J; Heath AW; Howard M
Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
[TBL] [Abstract][Full Text] [Related]
9. Endogenous expression of delta on the surface of WEHI-231. Characterization of its expression and signaling properties.
Haggerty HG; Wechsler RJ; Lentz VM; Monroe JG
J Immunol; 1993 Nov; 151(9):4681-93. PubMed ID: 8409428
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines.
Scott DW; O'Garra A; Warren D; Klaus GG
J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976
[TBL] [Abstract][Full Text] [Related]
11. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies.
Kim KM; Yoshimura T; Watanabe H; Ishigami T; Nambu M; Hata D; Higaki Y; Sasaki M; Tsutsui T; Mayumi M
J Immunol; 1991 Feb; 146(3):819-25. PubMed ID: 1988498
[TBL] [Abstract][Full Text] [Related]
12. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
Kelly K; Knox KA
Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
[TBL] [Abstract][Full Text] [Related]
13. The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies.
Boyd AW; Schrader JW
J Immunol; 1981 Jun; 126(6):2466-9. PubMed ID: 6785356
[TBL] [Abstract][Full Text] [Related]
14. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.
Nossal GJ; Pike BL; Battye FL
Immunology; 1979 May; 37(1):203-15. PubMed ID: 112040
[TBL] [Abstract][Full Text] [Related]
16. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
[TBL] [Abstract][Full Text] [Related]
17. Soluble anti-mu monoclonal antibodies prime resting B cells to secrete immunoglobulins in response to interleukins-4 and -5.
Phillips C; Klaus GG
Eur J Immunol; 1992 Jun; 22(6):1541-5. PubMed ID: 1601040
[TBL] [Abstract][Full Text] [Related]
18. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells.
Benhamou LE; Cazenave PA; Sarthou P
Eur J Immunol; 1990 Jun; 20(6):1405-7. PubMed ID: 2369921
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line.
Lee JR; Koretzky GA
J Immunol; 1998 Aug; 161(4):1637-44. PubMed ID: 9712025
[TBL] [Abstract][Full Text] [Related]
20. Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death.
Ishigami T; Kim KM; Horiguchi Y; Higaki Y; Hata D; Heike T; Katamura K; Mayumi M; Mikawa H
J Immunol; 1992 Jan; 148(2):360-8. PubMed ID: 1729359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]